Global Oncology Drugs Market Surges as Immunotherapy and Targeted Biologics Transform Cancer from a Terminal Illness to a Manageable Condition
The war on cancer is entering a decisive new chapter, marked by a departure from the "one-size-fits-all" approach of traditional chemotherapy. The global oncology drug landscape is now dominated by precision medicine, where treatments are designed to target specific molecular pathways or empower the body's own immune system to fight malignant cells. This shift has not only improved survival...
0 Comments 0 Shares 40 Views 0 Reviews